Masato Tsuneda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Masato Tsuneda has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Takashi Uno
Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan
6 shared publicationsKota Abe
Department of Radiation Oncology, MR Linac ART Division, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
4 shared publicationsYohei Ikeda
Department of Radiology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan
3 shared publicationsYukinao Abe
Department of Radiology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan
3 shared publicationsYukio Fujita
Department of Radiation Oncology MR Linac ART Division Graduate School of Medicine Chiba University Chiba Japan
3 shared publicationsAki Kanazawa
Department of Radiology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan
2 shared publications
Latest Publications
- Open Access
- 1 April 2026
- Published by Wolters Kluwer Health in Journal of Medical Physics
- Vol. 51 (2) , 249-254
Development of an End-to-end Phantom and Procedure for Computed Tomography and Cone-beam Computed Tomography-guided Online Adaptive Radiotherapy
Purpose: The purpose of this study was to develop an end-to-end (E2E) testing procedure to verify in-room computed tomography (CT)-on-rails and cone-beam CT (CBCT)-guided online adaptive radiation therapy (OART) workflows. Materials and Methods: A water tank-type lung phantom was developed to mimic the lung tissue and tumors, to evaluate deformable image registration (DIR) and dosimetry. Tumor shrinkage was mimicked by shape, position, and material changes. DIR was performed from the ellipsoidal tumor contoured on the initial CT image to multiple tumor cases on the CT and CBCT images. DIR accuracy was evaluated using the dice similarity coefficient (DSC) for manually delineated contours and those propagated by the adaptation anatomy algorithm. Dosimetric accuracy was evaluated by comparing the calculated and measured doses. An ionization chamber was used for point dose measurement, and a GafChromic film was used for gamma analysis using a 3%/2 mm criterion. Results: The averaged DSC values for the CT-guided and CBCT-guided OART workflows were 0.988 and 0.982, respectively. We confirmed high DSCs across different tumor conditions. The relative point dose differences between the measured and calculated doses for the CT-guided and CBCT-guided OART workflows were 0.02% and 0.86%, respectively. In the sagittal planes, the gamma passing rates were 97.8% and 95.6% for the CT-guided and CBCT-guided OART workflows, respectively, indicating good agreement between the measurements and calculations. Conclusion: We developed a novel lung phantom for E2E testing and established workflows for both CT-guided and CBCT-guided OART.
- 1 April 2026
- Published by Wolters Kluwer Health in Journal of Medical Physics
- Vol. 51 (2) , 249-254
Open AccessDevelopment of an End-to-end Phantom and Procedure for Computed Tomography and Cone-beam Computed Tomography-guided Online Adaptive Radiotherapy
Purpose: The purpose of this study was to develop an end-to-end (E2E) testing procedure to verify in-room computed tomography (CT)-on-rails and cone-beam CT (CBCT)-guided online adaptive radiation therapy (OART) workflows. Materials and Methods: A water tank-type lung phantom was developed to mimic the lung tissue and tumors, to evaluate deformable image registration (DIR) and dosimetry. Tumor shrinkage was mimicked by shape, position, and material changes. DIR was performed from the ellipsoidal tumor contoured on the initial CT image to multiple tumor cases on the CT and CBCT images. DIR accuracy was evaluated using the dice similarity coefficient (DSC) for manually delineated contours and those propagated by the adaptation anatomy algorithm. Dosimetric accuracy was evaluated by comparing the calculated and measured doses. An ionization chamber was used for point dose measurement, and a GafChromic film was used for gamma analysis using a 3%/2 mm criterion. Results: The averaged DSC values for the CT-guided and CBCT-guided OART workflows were 0.988 and 0.982, respectively. We confirmed high DSCs across different tumor conditions. The relative point dose differences between the measured and calculated doses for the CT-guided and CBCT-guided OART workflows were 0.02% and 0.86%, respectively. In the sagittal planes, the gamma passing rates were 97.8% and 95.6% for the CT-guided and CBCT-guided OART workflows, respectively, indicating good agreement between the measurements and calculations. Conclusion: We developed a novel lung phantom for E2E testing and established workflows for both CT-guided and CBCT-guided OART.
- Open Access
- 22 July 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 35, 100323
New workflow and motion analysis for gastric mucosa-associated lymphoid tissue lymphoma on a 1.5-T MR-Linac
- 22 July 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 35, 100323
Open AccessNew workflow and motion analysis for gastric mucosa-associated lymphoid tissue lymphoma on a 1.5-T MR-Linac
- Open Access
- 25 February 2025
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 26 (6) , e70059
Impact of bulk density assignment of bone on MRI‐based abdominal region radiotherapy planning for MR‐linac workflow
Purpose: The purpose of the present study was to evaluate the impact of bone relative electron density (rED) assignment on radiotherapy planning for the abdominal region.Methods: Twenty patients who received abdominal radiotherapy using MR‐Linac and underwent magnetic resonance imaging (MRI) and computed tomography (CT) simulation were analyzed. The reference plan (RP) was established using both CT and MR image sets (RP_CT and RP_MRI). The RP_MRI utilized the bulk density method. The recalculated RPs derived from various rED assignment methods were evaluated for comparison on both datasets. The RPs were recalculated by excluding rED assignment for bones (scenario A). Based on the International Commission on Radiation Units and Measurements report, lung contours were assigned rED of 0.258, and body contours were assigned 1.000 (scenario B) and 1.019 (scenario C). Dose volume histogram (DVH) differences between the three recalculated scenarios and RPs were evaluated. D95, D99, and D1cc were evaluated for target volumes, including gross tumor volume, internal target volume, and planning target volume. DVH parameters, including D1cc for each abdominal organ at risk (OAR) and the mean dose to the liver and kidneys, were evaluated. Three‐dimensional local gamma analysis was conducted to assess dose distribution differences between the three recalculated scenarios and RPs.Results: In all scenarios of the CT‐ and MRI‐based validation, the average gamma pass rates (2%/2 mm) were higher than 95%. In the CT‐based validation, all target DVHs across the 20 patients showed that none exceeded 2% error in scenario A, whereas 2% and 14% exceeded the threshold in scenarios B and C, respectively. For OARs in CT and MRI‐based validation, absolute maximum dose differences when compared with those of the RP were 0.19 Gy and 0.22 Gy, respectively, in scenario A.Conclusion: Excluding bone rED considerations in abdominal treatment planning may not yield notable clinical differences.
- 25 February 2025
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 26 (6) , e70059
Open AccessImpact of bulk density assignment of bone on MRI‐based abdominal region radiotherapy planning for MR‐linac workflow
Purpose: The purpose of the present study was to evaluate the impact of bone relative electron density (rED) assignment on radiotherapy planning for the abdominal region.Methods: Twenty patients who received abdominal radiotherapy using MR‐Linac and underwent magnetic resonance imaging (MRI) and computed tomography (CT) simulation were analyzed. The reference plan (RP) was established using both CT and MR image sets (RP_CT and RP_MRI). The RP_MRI utilized the bulk density method. The recalculated RPs derived from various rED assignment methods were evaluated for comparison on both datasets. The RPs were recalculated by excluding rED assignment for bones (scenario A). Based on the International Commission on Radiation Units and Measurements report, lung contours were assigned rED of 0.258, and body contours were assigned 1.000 (scenario B) and 1.019 (scenario C). Dose volume histogram (DVH) differences between the three recalculated scenarios and RPs were evaluated. D95, D99, and D1cc were evaluated for target volumes, including gross tumor volume, internal target volume, and planning target volume. DVH parameters, including D1cc for each abdominal organ at risk (OAR) and the mean dose to the liver and kidneys, were evaluated. Three‐dimensional local gamma analysis was conducted to assess dose distribution differences between the three recalculated scenarios and RPs.Results: In all scenarios of the CT‐ and MRI‐based validation, the average gamma pass rates (2%/2 mm) were higher than 95%. In the CT‐based validation, all target DVHs across the 20 patients showed that none exceeded 2% error in scenario A, whereas 2% and 14% exceeded the threshold in scenarios B and C, respectively. For OARs in CT and MRI‐based validation, absolute maximum dose differences when compared with those of the RP were 0.19 Gy and 0.22 Gy, respectively, in scenario A.Conclusion: Excluding bone rED considerations in abdominal treatment planning may not yield notable clinical differences.
- Open Access
- 10 May 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1335623
A pilot study on interobserver variability in organ-at-risk contours in magnetic resonance imaging-guided online adaptive radiotherapy for pancreatic cancer
Purpose: Differences in the contours created during magnetic resonance imaging-guided online adaptive radiotherapy (MRgOART) affect dose distribution. This study evaluated the interobserver error in delineating the organs at risk (OARs) in patients with pancreatic cancer treated with MRgOART. Moreover, we explored the effectiveness of drugs that could suppress peristalsis in restraining intra-fractional motion by evaluating OAR visualization in multiple patients.Methods: This study enrolled three patients who underwent MRgOART for pancreatic cancer. The study cohort was classified into three conditions based on the MRI sequence and butylscopolamine administration (Buscopan): 1, T2 imaging without butylscopolamine administration; 2, T2 imaging with butylscopolamine administration; and 3, multi-contrast imaging with butylscopolamine administration. Four blinded observers visualized the OARs (stomach, duodenum, small intestine, and large intestine) on MR images acquired during the initial and final MRgOART sessions. The contour was delineated on a slice area of ±2 cm surrounding the planning target volume. The dice similarity coefficient (DSC) was used to evaluate the contour. Moreover, the OARs were visualized on both MR images acquired before and after the contour delineation process during MRgOART to evaluate whether peristalsis could be suppressed. The DSC was calculated for each OAR.Results: Interobserver errors in the OARs (stomach, duodenum, small intestine, large intestine) for the three conditions were 0.636, 0.418, 0.676, and 0.806; 0.725, 0.635, 0.762, and 0.821; and 0.841, 0.677, 0.762, and 0.807, respectively. The DSC was higher in all conditions with butylscopolamine administration compared with those without it, except for the stomach in condition 2, as observed in the last session of MR image. The DSCs for OARs (stomach, duodenum, small intestine, large intestine) extracted before and after contouring were 0.86, 0.78, 0.88, and 0.87; 0.97, 0.94, 0.90, and 0.94; and 0.94, 0.86, 0.89, and 0.91 for conditions 1, 2, and 3, respectively.Conclusion: Butylscopolamine effectively reduced interobserver error and intra-fractional motion during the MRgOART treatment.
- 10 May 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1335623
Open AccessA pilot study on interobserver variability in organ-at-risk contours in magnetic resonance imaging-guided online adaptive radiotherapy for pancreatic cancer
Purpose: Differences in the contours created during magnetic resonance imaging-guided online adaptive radiotherapy (MRgOART) affect dose distribution. This study evaluated the interobserver error in delineating the organs at risk (OARs) in patients with pancreatic cancer treated with MRgOART. Moreover, we explored the effectiveness of drugs that could suppress peristalsis in restraining intra-fractional motion by evaluating OAR visualization in multiple patients.Methods: This study enrolled three patients who underwent MRgOART for pancreatic cancer. The study cohort was classified into three conditions based on the MRI sequence and butylscopolamine administration (Buscopan): 1, T2 imaging without butylscopolamine administration; 2, T2 imaging with butylscopolamine administration; and 3, multi-contrast imaging with butylscopolamine administration. Four blinded observers visualized the OARs (stomach, duodenum, small intestine, and large intestine) on MR images acquired during the initial and final MRgOART sessions. The contour was delineated on a slice area of ±2 cm surrounding the planning target volume. The dice similarity coefficient (DSC) was used to evaluate the contour. Moreover, the OARs were visualized on both MR images acquired before and after the contour delineation process during MRgOART to evaluate whether peristalsis could be suppressed. The DSC was calculated for each OAR.Results: Interobserver errors in the OARs (stomach, duodenum, small intestine, large intestine) for the three conditions were 0.636, 0.418, 0.676, and 0.806; 0.725, 0.635, 0.762, and 0.821; and 0.841, 0.677, 0.762, and 0.807, respectively. The DSC was higher in all conditions with butylscopolamine administration compared with those without it, except for the stomach in condition 2, as observed in the last session of MR image. The DSCs for OARs (stomach, duodenum, small intestine, large intestine) extracted before and after contouring were 0.86, 0.78, 0.88, and 0.87; 0.97, 0.94, 0.90, and 0.94; and 0.94, 0.86, 0.89, and 0.91 for conditions 1, 2, and 3, respectively.Conclusion: Butylscopolamine effectively reduced interobserver error and intra-fractional motion during the MRgOART treatment.
- Open Access
- 16 June 2023
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (7) , e14071
Delivery accuracy of VMAT on two beam‐matched linacs provided by accelerated go live service
Introduction: Dosimetric accuracy is critical when a patient treated with volumetric modulated arc therapy (VMAT) is transferred to another beam‐matched linac. To evaluate the performance of Accelerated Go Live (AGL) service, the measured beam characteristics and patient specific quality assurance (QA) results between two AGL‐matched linacs were compared.Materials and Methods: Two VersaHD linacs were installed using the AGL service. After the installation, the beam data such as percentage depth dose (PDD), lateral profiles and output factors for all photon beams were measured. Relative doses were also measured as a function of the multi‐leaf collimator (MLC) leaf gap width. Subsequently, VMAT plans were created for prostate, pelvis, head and neck, liver, lung cancers and multiple brain metastases. Dose distributions and point doses were measured by multi‐dimensional detectors and ionization chambers for patient specific quality assurance, and comparisons were made between the two linacs.Results: Dose differences in PDDs were all within ± 1% except the entrance region, and the averaged gamma indices of the lateral profiles were within 0.3. The differences in doses as a function of the MLC leaf gap width between the two linacs were within ±0.5%. For all the plans, gamma passing rates were all higher than 95% with criteria of 2%/2 mm. The average and the SD of dose differences on the multi‐dimensional detector between both measurements was 0.06 ± 2.12%, and the average of point dose differences was −0.03 ± 0.33%.Conclusion: We have evaluated the AGL performance in the context of beam characteristics and patient specific QA. It was demonstrated that the AGL service provides an accurate VMAT treatment reproducibility for many tumor sites with gamma pass rates greater than 95% under criteria of 2%/2 mm.
- 16 June 2023
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 24 (7) , e14071
Open AccessDelivery accuracy of VMAT on two beam‐matched linacs provided by accelerated go live service
Introduction: Dosimetric accuracy is critical when a patient treated with volumetric modulated arc therapy (VMAT) is transferred to another beam‐matched linac. To evaluate the performance of Accelerated Go Live (AGL) service, the measured beam characteristics and patient specific quality assurance (QA) results between two AGL‐matched linacs were compared.Materials and Methods: Two VersaHD linacs were installed using the AGL service. After the installation, the beam data such as percentage depth dose (PDD), lateral profiles and output factors for all photon beams were measured. Relative doses were also measured as a function of the multi‐leaf collimator (MLC) leaf gap width. Subsequently, VMAT plans were created for prostate, pelvis, head and neck, liver, lung cancers and multiple brain metastases. Dose distributions and point doses were measured by multi‐dimensional detectors and ionization chambers for patient specific quality assurance, and comparisons were made between the two linacs.Results: Dose differences in PDDs were all within ± 1% except the entrance region, and the averaged gamma indices of the lateral profiles were within 0.3. The differences in doses as a function of the MLC leaf gap width between the two linacs were within ±0.5%. For all the plans, gamma passing rates were all higher than 95% with criteria of 2%/2 mm. The average and the SD of dose differences on the multi‐dimensional detector between both measurements was 0.06 ± 2.12%, and the average of point dose differences was −0.03 ± 0.33%.Conclusion: We have evaluated the AGL performance in the context of beam characteristics and patient specific QA. It was demonstrated that the AGL service provides an accurate VMAT treatment reproducibility for many tumor sites with gamma pass rates greater than 95% under criteria of 2%/2 mm.
- Open Access
- 14 November 2022
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 64 (1) , 73-84
Elekta Unity MR-linac commissioning: mechanical and dosimetry tests
We report the commissioning results of Elekta Unity for the dosimetric performance and mechanical quality assurance (QA), and propose additional commissioning procedures. Mechanical tests included multi-leaf collimator (MLC) positional accuracy, radiation isocenter diameter at the center and off-center position, and coincidence between the magnetic resonance (MR) image center and radiation isocenter. Comparisons between the measurements and calculations of the simple irradiated field, intensity modulated radiation therapy (IMRT) commissioning, MLC output factor ratio, validation of independent dose calculation software and end-to-end testing were performed to evaluate dosimetric performance. The average values of the MLC positional accuracy for film- and imaging device-based analysis were −0.1 and 0.3 mm, respectively. The measured radiation isocenter size was 0.41 mm, and the off-center results were within 1 mm. The coincidence was −0.21, −1.19 and 0.49 mm along the x-, y- and z-axes, respectively. The calculated percent depth doses (PDD) and profiles agreed with the measurements. The results of independent dose calculation were within the action level recommended by American Associations of Physicist in Medicine. The gamma passing rate (GPR) for IMRT commissioning was 98.6 ± 0.9%, and end-to-end testing of adapted plans showed agreement within 2% between the measurement and calculation. We reported the results of mechanical and dosimetric performances of Elekta Unity, and proposed novel commissioning procedures. Our results should provide knowledge to the physics community for enhancing the QA programs.
- 14 November 2022
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 64 (1) , 73-84
Open AccessElekta Unity MR-linac commissioning: mechanical and dosimetry tests
We report the commissioning results of Elekta Unity for the dosimetric performance and mechanical quality assurance (QA), and propose additional commissioning procedures. Mechanical tests included multi-leaf collimator (MLC) positional accuracy, radiation isocenter diameter at the center and off-center position, and coincidence between the magnetic resonance (MR) image center and radiation isocenter. Comparisons between the measurements and calculations of the simple irradiated field, intensity modulated radiation therapy (IMRT) commissioning, MLC output factor ratio, validation of independent dose calculation software and end-to-end testing were performed to evaluate dosimetric performance. The average values of the MLC positional accuracy for film- and imaging device-based analysis were −0.1 and 0.3 mm, respectively. The measured radiation isocenter size was 0.41 mm, and the off-center results were within 1 mm. The coincidence was −0.21, −1.19 and 0.49 mm along the x-, y- and z-axes, respectively. The calculated percent depth doses (PDD) and profiles agreed with the measurements. The results of independent dose calculation were within the action level recommended by American Associations of Physicist in Medicine. The gamma passing rate (GPR) for IMRT commissioning was 98.6 ± 0.9%, and end-to-end testing of adapted plans showed agreement within 2% between the measurement and calculation. We reported the results of mechanical and dosimetric performances of Elekta Unity, and proposed novel commissioning procedures. Our results should provide knowledge to the physics community for enhancing the QA programs.
- 12 August 2021
- Published by Wiley in Medical Physics
- Vol. 48 (10) , 5639-5650
Plastic scintillation dosimeter with a conical mirror for measuring 3D dose distribution
Purpose: To test the measurement technique of the three‐dimensional (3D) dose distribution measured image by capturing the scintillation light generated using a plastic scintillator and a scintillating screen.Methods: Our imaging system constituted a column shaped plastic scintillator covered by a Gd2O2S:Tb scintillating screen, a conical mirror and a cooled CCD camera. The scintillator was irradiated with 6 MV photon beams. Meanwhile, the irradiated plan was prepared for the static field plans, two‐field plan (2F plan) and the conformal arc plan (CA plan). The 2F plan contained 16 mm2 and 10 mm2 fields irradiated from gantry angles of 0° and 25°, respectively. The gantry was rotated counterclockwise from 45° to 315° for the CA plan. The field size was then obtained as 10 mm2. A Monte Carlo simulation was performed in the experimental geometry to obtain the calculated 3D dose distribution as the reference data. Dose response was acquired by comparing between the reference and the measurement. The dose rate dependence was verified by irradiating the same MU value at different dose rates ranging from 100 to 600 MU/min. Deconvolution processing was applied to the measured images for the correction of light blurring. The measured 3D dose distribution was reconstructed from each measured image. Gamma analysis was performed to these 3D dose distributions. The gamma criteria were 3% for the dose difference, 2 mm for the distance‐to‐agreement and 10% for the threshold.Results: Dose response for the scintillation light was linear. The variation in the light intensity for the dose rate ranging from 100 to 600 MU/min was less than 0.5%, while our system presents dose rate independence. For the 3D dose measurement, blurring of light through deconvolution processing worked well. The 3D gamma passing rate (3D GPR) for the 10 × 10 mm2, 16 × 16 mm2, and 20 × 20 mm2 fields were observed to be 99.3%, 98.8%, and 97.8%, respectively. Reproducibility of measurement was verified. The 3D GPR results for the 2F plan and the CA plan were 99.7% and 100%, respectively.Conclusions: We developed a plastic scintillation dosimeter and demonstrated that our system concept can act as a suitable technique for measuring the 3D dose distribution from the gamma results. In the future, we will attempt to measure the 4D dose distribution for clinical volumetric modulated arc radiation therapy (VMAT)‐SBRTplans.
- 12 August 2021
- Published by Wiley in Medical Physics
- Vol. 48 (10) , 5639-5650
Plastic scintillation dosimeter with a conical mirror for measuring 3D dose distribution
Purpose: To test the measurement technique of the three‐dimensional (3D) dose distribution measured image by capturing the scintillation light generated using a plastic scintillator and a scintillating screen.Methods: Our imaging system constituted a column shaped plastic scintillator covered by a Gd2O2S:Tb scintillating screen, a conical mirror and a cooled CCD camera. The scintillator was irradiated with 6 MV photon beams. Meanwhile, the irradiated plan was prepared for the static field plans, two‐field plan (2F plan) and the conformal arc plan (CA plan). The 2F plan contained 16 mm2 and 10 mm2 fields irradiated from gantry angles of 0° and 25°, respectively. The gantry was rotated counterclockwise from 45° to 315° for the CA plan. The field size was then obtained as 10 mm2. A Monte Carlo simulation was performed in the experimental geometry to obtain the calculated 3D dose distribution as the reference data. Dose response was acquired by comparing between the reference and the measurement. The dose rate dependence was verified by irradiating the same MU value at different dose rates ranging from 100 to 600 MU/min. Deconvolution processing was applied to the measured images for the correction of light blurring. The measured 3D dose distribution was reconstructed from each measured image. Gamma analysis was performed to these 3D dose distributions. The gamma criteria were 3% for the dose difference, 2 mm for the distance‐to‐agreement and 10% for the threshold.Results: Dose response for the scintillation light was linear. The variation in the light intensity for the dose rate ranging from 100 to 600 MU/min was less than 0.5%, while our system presents dose rate independence. For the 3D dose measurement, blurring of light through deconvolution processing worked well. The 3D gamma passing rate (3D GPR) for the 10 × 10 mm2, 16 × 16 mm2, and 20 × 20 mm2 fields were observed to be 99.3%, 98.8%, and 97.8%, respectively. Reproducibility of measurement was verified. The 3D GPR results for the 2F plan and the CA plan were 99.7% and 100%, respectively.Conclusions: We developed a plastic scintillation dosimeter and demonstrated that our system concept can act as a suitable technique for measuring the 3D dose distribution from the gamma results. In the future, we will attempt to measure the 4D dose distribution for clinical volumetric modulated arc radiation therapy (VMAT)‐SBRTplans.
- Open Access
- 1 December 2020
- Published by Elsevier in Physica Medica
- Vol. 80, 84-91
Feasibility of image quality improvement for high-speed CBCT imaging using deep convolutional neural network for image-guided radiotherapy in prostate cancer
- 1 December 2020
- Published by Elsevier in Physica Medica
- Vol. 80, 84-91
Open AccessFeasibility of image quality improvement for high-speed CBCT imaging using deep convolutional neural network for image-guided radiotherapy in prostate cancer
- Open Access
- 1 January 2018
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 23 (1) , 50-56
Energy spectrum and dose enhancement due to the depth of the Lipiodol position using flattened and unflattened beams
Lipiodol was used for stereotactic body radiotherapy combining trans arterial chemoembolization. Lipiodol used for tumour seeking in trans arterial chemoembolization remains in stereotactic body radiation therapy. In our previous study, we reported the dose enhancement effect in Lipiodol with 10× flattening-filter-free (FFF). The objective of our study was to evaluate the dose enhancement and energy spectrum of photons and electrons due to the Lipiodol depth with flattened (FF) and FFF beams. FF and FFF for 6 MV beams from TrueBeam were used in this study. The Lipiodol (3 × 3 × 3 cm3) was located at depths of 1, 3, 5, 10, 20, and 30 cm in water. The dose enhancement factor (DEF) and the energy fluence were obtained by Monte Carlo calculations of the particle and heavy ion transport code system (PHITS). The DEFs at the centre of Lipiodol with the FF beam were 6.8, 7.3, 7.6, 7.2, 6.1, and 5.7% and those with the FFF beam were 20.6, 22.0, 21.9, 20.0, 12.3, and 12.1% at depths of 1, 3, 5, 10, 20, and 30 cm, respectively, where Lipiodol was located in water. Moreover, spectrum results showed that more low-energy photons and electrons were present at shallow depth where Lipiodol was located in water. The variation in the low-energy spectrum due to the depth of the Lipiodol position was more explicit with the FFF beam than that with the FF beam. The current study revealed variations in the DEF and energy spectrum due to the depth of the Lipiodol position with the FF and FFF beams. Although the FF beam could reduce the effect of energy dependence due to the depth of the Lipiodol position, the dose enhancement was overall small. To cause a large dose enhancement, the FFF beam with the distance of the patient surface to Lipiodol within 10 cm should be used.
- 1 January 2018
- Published by VM Media Group sp. z o.o in Reports of Practical Oncology and Radiotherapy
- Vol. 23 (1) , 50-56
Open AccessEnergy spectrum and dose enhancement due to the depth of the Lipiodol position using flattened and unflattened beams
Lipiodol was used for stereotactic body radiotherapy combining trans arterial chemoembolization. Lipiodol used for tumour seeking in trans arterial chemoembolization remains in stereotactic body radiation therapy. In our previous study, we reported the dose enhancement effect in Lipiodol with 10× flattening-filter-free (FFF). The objective of our study was to evaluate the dose enhancement and energy spectrum of photons and electrons due to the Lipiodol depth with flattened (FF) and FFF beams. FF and FFF for 6 MV beams from TrueBeam were used in this study. The Lipiodol (3 × 3 × 3 cm3) was located at depths of 1, 3, 5, 10, 20, and 30 cm in water. The dose enhancement factor (DEF) and the energy fluence were obtained by Monte Carlo calculations of the particle and heavy ion transport code system (PHITS). The DEFs at the centre of Lipiodol with the FF beam were 6.8, 7.3, 7.6, 7.2, 6.1, and 5.7% and those with the FFF beam were 20.6, 22.0, 21.9, 20.0, 12.3, and 12.1% at depths of 1, 3, 5, 10, 20, and 30 cm, respectively, where Lipiodol was located in water. Moreover, spectrum results showed that more low-energy photons and electrons were present at shallow depth where Lipiodol was located in water. The variation in the low-energy spectrum due to the depth of the Lipiodol position was more explicit with the FFF beam than that with the FF beam. The current study revealed variations in the DEF and energy spectrum due to the depth of the Lipiodol position with the FF and FFF beams. Although the FF beam could reduce the effect of energy dependence due to the depth of the Lipiodol position, the dose enhancement was overall small. To cause a large dose enhancement, the FFF beam with the distance of the patient surface to Lipiodol within 10 cm should be used.